An evaluation of alirocumab for the treatment of hypercholesterolemia.
about
Future Lipid-Altering Therapeutic Options Targeting Residual Cardiovascular Risk.Alirocumab for the treatment of hyperlipidemia in high-risk patients: an updated review.Lowering low-density lipoprotein cholesterol by PCSK9 inhibition in patients with diabetes on insulin therapy: is it efficacious and safe?
P2860
An evaluation of alirocumab for the treatment of hypercholesterolemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
An evaluation of alirocumab for the treatment of hypercholesterolemia.
@en
type
label
An evaluation of alirocumab for the treatment of hypercholesterolemia.
@en
prefLabel
An evaluation of alirocumab for the treatment of hypercholesterolemia.
@en
P2860
P1476
An evaluation of alirocumab for the treatment of hypercholesterolemia.
@en
P2093
Michel Farnier
P2860
P304
P356
10.1586/14779072.2015.1111759
P577
2015-11-13T00:00:00Z